Edwards Lifesciences Corporation Share Price
Equities
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.84 USD | +1.00% |
|
-2.34% | -1.65% |
| Capitalization | 4.87TCr 4.18TCr 3.9TCr 3.62TCr 6.76TCr 4,39400Cr 7.29TCr 45TCr 18TCr 2,10000Cr 18TCr 18TCr 7,74400Cr | P/E ratio 2025 * |
37x | P/E ratio 2026 * | 30.9x |
|---|---|---|---|---|---|
| Enterprise value | 4.52TCr 3.88TCr 3.62TCr 3.36TCr 6.28TCr 4,08100Cr 6.77TCr 42TCr 16TCr 1,95000Cr 17TCr 17TCr 7,19200Cr | EV / Sales 2025 * |
7.49x | EV / Sales 2026 * | 6.64x |
| Free-Float |
89.32% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +1.00% | ||
| 1 week | -2.34% | ||
| Current month | -1.65% | ||
| 1 month | +0.91% | ||
| 3 months | +14.93% | ||
| 6 months | +7.42% | ||
| Current year | -1.65% |
| 1 week | 82.56 |  | 86.1 |
| 1 month | 81.85 | | 87.44 |
| Current year | 82.56 | | 86.6 |
| 1 year | 65.94 | | 87.89 |
| 3 years | 58.93 | | 96.12 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 24.07 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Scott Ullem
DFI | Director of Finance/CFO | 59 | 01/01/2014 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +1.15% | 2.46% | 51 M€ | |
| +1.18% | 2.34% | 26 M€ | |
| +0.03% | 1.17% | 27 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.00% | -2.34% | +17.94% | +7.06% | 4.82TCr | |
| -1.36% | -2.20% | +9.28% | +3.98% | 23TCr | |
| -1.91% | -5.23% | +4.09% | +117.00% | 20TCr | |
| -1.44% | -0.44% | -1.80% | -13.91% | 17TCr | |
| -1.65% | -3.73% | -0.50% | +102.32% | 14TCr | |
| -0.49% | +1.39% | -7.88% | -6.18% | 6.12TCr | |
| -1.13% | -0.87% | +3.08% | -6.76% | 4.2TCr | |
| -2.45% | -2.26% | -0.69% | +29.54% | 3.96TCr | |
| -1.23% | +2.20% | +10.60% | +16.77% | 3.76TCr | |
| +0.09% | +2.10% | -10.04% | -37.06% | 3.61TCr | |
| Average | -1.06% | -0.98% | +2.41% | +21.28% | 10.1TCr | |
| Weighted average by Cap. | -1.34% | -2.09% | +3.09% | +36.64% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 603.21Cr 518.34Cr 483.37Cr 449.15Cr 838.05Cr 54TCr 903.67Cr 5.56TCr 2.18TCr 26TCr 2.26TCr 2.22TCr 96TCr | 661.66Cr 568.56Cr 530.2Cr 492.67Cr 919.25Cr 60TCr 991.23Cr 6.1TCr 2.39TCr 29TCr 2.48TCr 2.43TCr 1,05300Cr |
| Net income | 131.68Cr 113.15Cr 105.52Cr 98Cr 182.95Cr 12TCr 197.27Cr 1.21TCr 476.65Cr 5.68TCr 493.84Cr 483.71Cr 21TCr | 158.31Cr 136.04Cr 126.86Cr 117.88Cr 219.95Cr 14TCr 237.17Cr 1.46TCr 573.05Cr 6.83TCr 593.71Cr 581.53Cr 25TCr |
| Net Debt | -347.06Cr -298.23Cr -278.11Cr -258.42Cr -482.18Cr -31TCr -519.93Cr -3.2TCr -1.26TCr -15TCr -1.3TCr -1.27TCr -55TCr | -473.5Cr -406.88Cr -379.42Cr -352.57Cr -657.84Cr -43TCr -709.35Cr -4.36TCr -1.71TCr -20TCr -1.78TCr -1.74TCr -75TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 83.84 $ | +1.00% | 40,61,253 |
| 12/26/12 | 83.01 $ | -2.49% | 32,45,240 |
| 09/26/09 | 85.13 $ | +0.65% | 33,83,855 |
| 08/26/08 | 84.58 $ | -0.29% | 37,38,686 |
| 07/26/07 | 84.83 $ | -1.19% | 42,87,234 |
Delayed Quote Nyse, January 14, 2026 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition